Work

Dual G1 and G2 phase inhibition by a novel, selective Cdc25 inhibitor 7-chloro-6-(2-morpholin-4-ylethyl- amino)-quinoline-5,8-dione.

Year: 2003

Type: article

Abstract: Page 46877. There is an error in the title, abstract, and abbreviations. The compound NSC 663284 should be 6-chloro-7-(2-morpholin-4-ylethylamino)-quinoline-5,8-dione and not 7-chloro-6-(2-morpholin-4-ylethylamino)-quinoline-5,8-dione. This correction does not affect the conclusions in any way. The correct chemical structure of the compound is indicated in Fig. 12 on page 46885.

Source: Journal of Biological Chemistry

DOI: 10.1016/s0021-9258(19)64619-3

Authors: Lixia Pu, Andrew A. Amoscato, Mark E. Bier, John S. Lazo

Language: English

Topic: Cancer-related Molecular Pathways

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $3,430

OpenAlex ID: W4246787562

FWCI: 0.15

Cites:

Cited by: 2

Related to: 10